The letter published in the Canadian Journal of Neurological Sciences critiques a reported case of recovery from rabies using intrathecal rabies immune globulin, highlighting numerous flaws in the treatment approach. Concerns are raised about the lack of compliance with World Health Organization recommendations, insufficient details about the case, and questionable laboratory evaluations. The authors recommend caution in considering similar treatment approaches due to uncertainties surrounding the reported case and the delivery method of intrathecal RIG.